Ocugen is trading 5.00% down at MXN 15.20 on October 16, 2026, with the cause unclear. - No company-specific announcement directly explains the decline. Recent company news included an OCU400 licensing agreement announced October 14. - Inflation and interest-rate concerns have resurfaced, but available evidence does not establish that macro pressure caused this move. - The biotech sector is reported higher. No verified direct catalyst or market-wide confirmation explains this particular move.